18A Peptide | CAS: 157675-61-1 | EWLKAFYEKVLEKLKELF

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

18A Peptide (CAS 157675-61-1)

US$725.40

Excluding tax and shipping fees

In stock

Description

About 18A Peptide (CAS 157675-61-1)

18A is a self-aggregating peptide fusion tag that can drive target proteins into active protein aggregates in vivo (e.g. in E.coli for recombinant proteins). For research use only, do not use in humans!

18A Peptide (CAS 157675-61-1) - Specifications

Peptide sequence: Ac-EWLKAFYEKVLEKLKELF-NH2 (synthetic)

Amount: 20 mg net (AAA)

Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

MW (average): 2354.7800000000002

Application(s): Tissue engineering, Drug delivery

Condition(s)/Topic(s): Regenerative medicine

Standard Delivery Time: 2-5 days

CAS: 157675-61-1

JPT’s Hydrogel Forming Peptides

Peptide-based hydrogels or peptide nanogels stand out due to their biocompatibility and biodegradability, which make them ideal for biomedical applications. These nanogels self-assemble in aqueous solutions without the need for gelators, cross-linkers, or mechanical stimulators, forming hydrogel scaffolds that closely resemble the architecture of the extracellular matrix (ECM). JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

All peptides are made in Germany

Bulk orders or custom peptide synthesis upon request

Provision of freeze-dried aliquots for enhanced stability

Proven track record

Need the conjugated or modified peptide? Contact us!

References

References for 18A Peptide (CAS 157675-61-1)

References:Read References with Specialty PeptidesTestimonial:"Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle."Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Testimonial:Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle.Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Documentation

Documentation for 18A Peptide (CAS 157675-61-1)

18A-Peptide-CAS-157675-61-1.pdf

Properties

Properties of 18A Peptide (CAS 157675-61-1)

20 mg net (AAA)

Drug delivery, Tissue engineering

Hydrogel Forming Peptides

Regenerative medicine

Freeze-dried in plastic vial

Artificial

Self-assembling peptide

Trial Grade: each peptide purified to > 90% (HPLC/MS)

Yes

Further Information to 18A Peptide (CAS 157675-61-1)

Values

Ac-EWLKAFYEKVLEKLKELF-NH2 (synthetic)